HIF prolyl hydroxylase-3 mediates alpha-ketoglutarate-induced apoptosis and tumor suppression.
Many solid tumors consist of large regions of poorly perfused cells, resulting in areas of low oxygen (hypoxia) throughout the cell mass. Cells subjected to hypoxia turn on a complex set of responses that alter their metabolism, rebalance their survival mechanisms, increase their invasive capacity, and stimulate angiogenesis. This allows them to at least temporarily escape the nutrient starvation and cell death resulting from this hostile environment. Accordingly, the hypoxic regions of tumors are often sources of the most aggressive and therapy-resistant cells, and therefore those cells that drive tumorigenesis. The hypoxia inducible factor (HIF) prolyl hydroxylases (PHDs) are enzymes that are functionally inactivated in hypoxia, as they use both oxygen and alpha-ketoglutarate as substrates to hydroxylate target prolyl residues. Although HIF1alpha, the most highly characterized PHD target, orchestrates many of the cellular responses to hypoxia observed in tumors, PHDs themselves have previously been shown to regulate some hypoxia responses, including apoptosis, in a HIF-independent mechanism. We have previously shown that PHDs can be reactivated under hypoxia and that this results in a metabolic defect, both in vitro and in vivo. This led us to investigate whether chronic reactivation of these enzymes may inhibit tumor progression. We show here that esterified alpha-ketoglutarate given daily will induce apoptosis and inhibit tumor growth, in vivo. The effects are independent of HIF1alpha but dependent on the presence of PHD3. These data suggest that PHD3 may be a valid target in vivo for anti-tumor therapy.
Tennant
Daniel A
DA
Cancer Research UK, The Beatson Institute for Cancer Research, Glasgow, UK.
Gottlieb
Eyal
E
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D015687:Cell Hypoxia; D045744:Cell Line, Tumor; D049308:Dioxygenases / Q000378:metabolism*; D005260:Female; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000378:metabolism; D064799:Hypoxia-Inducible Factor-Proline Dioxygenases; D007656:Ketoglutaric Acids / Q000378:metabolism / Q000627:therapeutic use*; D051379:Mice; D008819:Mice, Nude; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology
D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D007656:Ketoglutaric Acids; D049308:Dioxygenases; C488894:EGLN3 protein, human; D064799:Hypoxia-Inducible Factor-Proline Dioxygenases
Mol Cell Biol. 2008 May;28(10):3386-400
18332118
Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5510-4
7539918
EMBO J. 2003 Aug 15;22(16):4082-90
12912907
N Engl J Med. 2008 Dec 18;359(25):2685-92
19092153
Oncogene. 2002 Jan 24;21(5):836-43
11850811
Cell. 2001 Oct 5;107(1):43-54
11595184
Gastroenterology. 2010 Mar;138(3):1143-54.e1-2
19818783
Biol Chem. 2004 Mar-Apr;385(3-4):223-30
15134335
Science. 2001 Nov 9;294(5545):1337-40
11598268
J Biol Chem. 1996 Jul 26;271(30):17771-8
8663540
Nat Genet. 2008 Feb;40(2):170-80
18176562
J Physiol. 2004 Oct 1;560(Pt 1):21-6
15319416
Cancer Res. 2003 Dec 15;63(24):8777-83
14695194
Br J Cancer. 2009 Oct 6;101(7):1168-74
19724277
Gene. 2001 Sep 5;275(1):125-32
11574160
Cancer Cell. 2009 Jun 2;15(6):527-38
19477431
Cancer Cell. 2005 Jan;7(1):77-85
15652751
Cancer Res. 2003 Apr 15;63(8):1764-8
12702559
J Biol Chem. 2003 Aug 15;278(33):30772-80
12788921
Nat Rev Drug Discov. 2009 Feb;8(2):139-52
19165233
Nat Rev Mol Cell Biol. 2008 Apr;9(4):285-96
18285802
Oncogene. 2009 Nov 12;28(45):4009-21
19718054
Nat Rev Cancer. 2002 Jan;2(1):38-47
11902584
Biochem Pharmacol. 2007 Feb 1;73(3):450-7
17101119
Nat Rev Mol Cell Biol. 2004 May;5(5):343-54
15122348
Mol Oncol. 2008 Jun;2(1):41-53
19383328
Mol Biol Cell. 2007 Nov;18(11):4528-42
17804822
Exp Cell Res. 2005 May 15;306(1):274-84
15878351
Cancer Cell. 2009 Nov 6;16(5):413-24
19878873
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9630-5
11504942
Mol Cell Biol. 2007 Feb;27(3):912-25
17101781
Expert Rev Mol Med. 2009 Aug 27;11:e26
19709449
Cell. 2009 Mar 6;136(5):839-851
19217150
Eur J Haematol. 2010 Jan 1;84(1):47-51
19737309
Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8104-9
9223322
Cancer Cell. 2005 Aug;8(2):155-67
16098468
Nat Rev Cancer. 2008 Dec;8(12):967-75
18987634
Am J Pathol. 2000 Aug;157(2):411-21
10934146
Sci Signal. 2009 Jul 07;2(78):ra33
19584355
Genes Dev. 2008 Apr 1;22(7):884-93
18334619